Fernández-Espartero, M.C., Pérez-Zafrilla, B., Naranjo, A., et al. (2010) Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review. Seminars in Arthritis and Rheumatism, 40, 330-337.
https://doi.org/10.1016/j.semarthrit.2010.06.004

has been cited by the following article:

• TITLE: Peripheral Neuropathy under Infliximab Therapy: About One Case

  AUTHORS: Fatima-Zahra Hamdoun, Hakima Abid, Nada Lahmidani, Mounia El Yousfi, Dafr-Allah Benajah, Mohammed El Abkari, Adil Ibrahimi

  KEYWORDS: Crohn’s Disease, Infliximab, Peripheral Neuropathy

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.10 No.9, September 27, 2020

  ABSTRACT: A-TNF inhibitors are increasingly used in various inflammatory disorders. Multiple side effects have been reported in recent years, particularly peripheral neuropathies. We report a case of axonal neuropathy occurring after the start of treatment with Infliximab. This is a 47 years old patient, followed for Crohn’s disease requiring treatment with Infliximab. Twenty-two weeks later, the patient presented a grade 4 of axonal neuropathy. We concluded to a medicinal sensitive neuropathy after elimination of other etiologies. Given the severity of the neurological symptoms, we decided to change the therapeutic class.